Creata Pharmaceuticals

Prescription medicines for therapeutic areas in healthcare.

About Creata Pharmaceuticals

Creata Pharmaceuticals is a Healthcare company. Prescription medicines for therapeutic areas in healthcare. Its Indian entity Creata Pharmaceuticals (I) Private Limited reported revenue of β‚Ή18.1 Lakh. Creata Pharmaceuticals offers products and services including Prescription Medicines and Health and Wellness Products. Its focus areas include Pharmaceuticals, Prescription Medicines, Therapeutic Drugs and Wellness.

Company details

Creata Pharmaceuticals is recognized as an innovative enterprise that emphasizes the scientific focus on health and wellness. Its product portfolio includes prescription medicines for central nervous system disorders, muscle spasm, vertigo, migraine, gastrointestinal disorders, and peripheral neuropathy. High-quality products are manufactured under WHO, GMP, IAS-ANZ, and ISO standards, while customer satisfaction is prioritized through ethical business practices. Operations are based in Kolkata, India, with a commitment to compliance with laws and regulations. This approach ensures that health needs are met effectively.

Key Metrics
  • Indian entity revenue
    ₹18.1 Lakh

    FY 2024 · +2% YoY

  • Indian entity net profit
    ₹5,384

    FY 2024 · 0% margin

  • Indian entity EBITDA
    ₹10,107

    FY 2024 · 1% margin

Products & Services of Creata Pharmaceuticals

Creata Pharmaceuticals offers a comprehensive portfolio of products and services, including Prescription Medicines and Health and Wellness Products.

Prescription Medicines
Therapeutic Drugs

Prescription medicines for various disorders are developed and distributed in the areas of central nervous system, muscle spasm, vertigo, migraine, gastrointestinal issues, and peripheral neuropathy.

Health and Wellness Products
Pharmaceuticals

Health and wellness products that embody a vision on scientific emphasis are provided.

Board of directors of Creata Pharmaceuticals (I) Private Limited (Creata Pharmaceuticals)

Creata Pharmaceuticals (I) Private Limited is the primary company behind Creata Pharmaceuticals. The board of Creata Pharmaceuticals (I) Private Limited currently have 2 directors; the longest-serving is Mithilesh, appointed in 2016.

DirectorDesignationAppointedTenureEntity
Mithilesh
DIN 07565011
Director04 Aug 201610 yrs 3 moCreata Pharmaceuticals (I) Private Limited
Brijesh Kumar Shukla
DIN 07565055
Managing Director04 Aug 201610 yrs 3 moCreata Pharmaceuticals (I) Private Limited

Financials of Creata Pharmaceuticals

Figures of Creata Pharmaceuticals (I) Private Limited, the primary company behind Creata Pharmaceuticals, for FY 2024. Revenue was ₹18.1 Lakh (+2% year on year). Net profit was ₹5,384 (0% margin). EBITDA was ₹10,107 (1% margin). Revenue has grown at a compounded annual rate of +8% over three years and -1% over five years.

  • ₹18.1 LakhRevenue · FY 2024 · +2% YoY
  • ₹5,384Net profit · 0% margin
  • ₹10,107EBITDA · 1% margin
  • ₹1.2 LakhPaid-up capital
  • +8%Revenue CAGR, 3 years
  • -1%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Creata Pharmaceuticals (I) Private Limited are on its company page.

Premium access

Detailed financial statements for Creata Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Creata Pharmaceuticals

The primary company behind Creata Pharmaceuticals, Creata Pharmaceuticals (I) Private Limited, reported revenue of β‚Ή18.1 Lakh for FY 2024, up 2% year on year.

Creata Pharmaceuticals is recognized as an innovative enterprise that emphasizes the scientific focus on health and wellness. Its product portfolio includes prescription medicines for central nervous system disorders, muscle spasm, vertigo, migraine, gastrointestinal disorders, and peripheral neuropathy. High-quality products are manufactured under WHO, GMP, IAS-ANZ, and ISO standards, while customer satisfaction is prioritized through ethical business practices. Operations are based in Kolkata, India, with a commitment to compliance with laws and regulations. This approach ensures that health needs are met effectively.

Creata Pharmaceuticals offers Prescription Medicines and Health and Wellness Products.

Creata Pharmaceuticals operates through Creata Pharmaceuticals (I) Private Limited.

The legal entities of Creata Pharmaceuticals currently have 2 directors, including Mithilesh, Brijesh Kumar Shukla.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available